These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31609189)

  • 21. Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain.
    García-Carmona JA; Simal-Aguado J; Campos-Navarro MP; Valdivia-Muñoz F; Galindo-Tovar A
    Int Clin Psychopharmacol; 2021 Jul; 36(4):201-207. PubMed ID: 33853106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.
    Apiquian R; Fresán A; de la Fuente-Sandoval C; Ulloa RE; Nicolini H
    BMC Psychiatry; 2004 Apr; 4():12. PubMed ID: 15109398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Off-label use of atypical antipsychotics in personality disorders.
    Rosenbluth M; Sinyor M
    Expert Opin Pharmacother; 2012 Aug; 13(11):1575-85. PubMed ID: 21933032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring for the metabolic side effects of second-generation antipsychotic medications: Psychiatrists' views and practices.
    Abdulhaq B; Dardas LA; Sami O
    Perspect Psychiatr Care; 2021 Jul; 57(3):1237-1243. PubMed ID: 33156542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain.
    Pascual JC; Martín-Blanco A; Soler J
    CNS Drugs; 2021 Sep; 35(9):1023-1032. PubMed ID: 34370282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overdose and off-label psychotropic prescribing in patients with borderline personality disorder: A retrospective series.
    Ning AY; Theodoros T; Harris K; Isoardi KZ
    Australas Psychiatry; 2023 Apr; 31(2):195-200. PubMed ID: 36772817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PRESCRIPTION PATTERNS IN THE TREATMENT OF SCHIZOPHRENIA].
    Leiderman EA; Lorenzo L
    Vertex; 2015; 26(119):11-6. PubMed ID: 26323108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis.
    Stogios N; Smith E; Bowden S; Tran V; Asgariroozbehani R; McIntyre WB; Remington G; Siskind D; Agarwal SM; Hahn MK
    Neuropsychopharmacology; 2022 Feb; 47(3):664-672. PubMed ID: 34446830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
    Bozzatello P; Rocca P; Uscinska M; Bellino S
    CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
    de Kuijper GM; Hoekstra PJ
    J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics.
    Samalin L; Garnier M; Auclair C; Llorca PM
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study on the prescribing patterns of antipsychotic medication in a rural England Community Mental Health Team.
    Seshadri M; Elsemary A; Thalitaya MD; Chikodzore L; Nagalingam P
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):524-529. PubMed ID: 28953820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the Appropriateness of Off-Label Antipsychotic Use for Mental Health Indications in a Veteran Population.
    Painter JT; Owen R; Henderson KL; Bauer MS; Mittal D; Hudson TJ
    Pharmacotherapy; 2017 Apr; 37(4):438-446. PubMed ID: 28164355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness.
    Llorca PM; Abbar M; Courtet P; Guillaume S; Lancrenon S; Samalin L
    BMC Psychiatry; 2013 Dec; 13():340. PubMed ID: 24359031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological interventions for people with borderline personality disorder.
    Stoffers-Winterling JM; Storebø OJ; Pereira Ribeiro J; Kongerslev MT; Völlm BA; Mattivi JT; Faltinsen E; Todorovac A; Jørgensen MS; Callesen HE; Sales CP; Schaug JP; Simonsen E; Lieb K
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD012956. PubMed ID: 36375174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off-label second generation antipsychotics for impulse regulation disorders: a review.
    Scheltema Beduin A; de Haan L
    Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination Therapy of Long-Acting Injectable Second-Generation Antipsychotics and Oral Antipsychotics: A Retrospective Chart Review and Prescribers' Attitude Survey.
    Misawa F; Amemiya A; Fujii Y; Takeuchi H
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):81-86. PubMed ID: 34668878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines.
    Riffer F; Farkas M; Streibl L; Kaiser E; Sprung M
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):178-188. PubMed ID: 31140337
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and tolerability of pharmacotherapies for borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    CNS Drugs; 2008; 22(8):671-92. PubMed ID: 18601305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.